{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T12:06:38Z","timestamp":1749211598003,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10549-019-05328-3","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T14:20:41Z","timestamp":1561386041000},"page":"469-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer"],"prefix":"10.1007","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0347-2196","authenticated-orcid":false,"given":"Y.","family":"Andersson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bergkvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Frisell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"de Boniface","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"issue":"2","key":"5328_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/bjs.7820","volume":"99","author":"Y Andersson","year":"2012","unstructured":"Andersson Y, de Boniface J, Jonsson PE, Ingvar C, Liljegren G, Bergkvist L, Frisell J (2012) Swedish Breast Cancer G, Swedish Society of Breast S: axillary recurrence rate 5\u00a0years after negative sentinel node biopsy for breast cancer. Br J Surg 99(2):226\u2013231","journal-title":"Br J Surg"},{"issue":"10","key":"5328_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927\u2013933","journal-title":"Lancet Oncol"},{"issue":"2","key":"5328_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10549-010-1210-7","volume":"125","author":"MJ Pepels","year":"2011","unstructured":"Pepels MJ, Vestjens JH, de Boer M, Smidt M, van Diest PJ, Borm GF, Tjan-Heijnen VC (2011) Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat 125(2):301\u2013313","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"5328_CR4","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.ejso.2008.01.034","volume":"34","author":"IM van der Ploeg","year":"2008","unstructured":"van der Ploeg IM, Nieweg OE, van Rijk MC, Valdes Olmos RA, Kroon BB (2008) Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 34(12):1277\u20131284","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"5328_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jamcollsurg.2007.08.024","volume":"206","author":"CE Cox","year":"2008","unstructured":"Cox CE, Kiluk JV, Riker AI, Cox JM, Allred N, Ramos DC, Dupont EL, Vrcel V, Diaz N, Boulware D (2008) Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg 206(2):261\u2013268","journal-title":"J Am Coll Surg"},{"issue":"4","key":"5328_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/cncr.22847","volume":"110","author":"RF Hwang","year":"2007","unstructured":"Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK (2007) Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110(4):723\u2013730","journal-title":"Cancer"},{"issue":"5","key":"5328_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1200\/JCO.2007.14.4667","volume":"26","author":"EJ Rutgers","year":"2008","unstructured":"Rutgers EJ (2008) Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. J Clin Oncol 26(5):698\u2013702","journal-title":"J Clin Oncol"},{"issue":"3","key":"5328_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4048\/jbc.2018.21.e44","volume":"21","author":"J Lee","year":"2018","unstructured":"Lee J, Choi JE, Kim SJ, Lee SB, Seong MK, Jeong J, Yoon CS, Kim BK, Sun WY (2018) Comparative study between sentinel lymph node biopsy and axillary dissection in patients with one or two lymph node metastases. J Breast Cancer 21(3):306\u2013314","journal-title":"J Breast Cancer"},{"issue":"4","key":"5328_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.amjsurg.2018.07.027","volume":"216","author":"A Nayyar","year":"2018","unstructured":"Nayyar A, Strassle PD, Shen MR, Black JA, Gallagher KK, McGuire KP (2018) Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection. Am J Surg 216(4):706\u2013712","journal-title":"Am J Surg"},{"issue":"3","key":"5328_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK (2016) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg 264(3):413\u2013420","journal-title":"Ann Surg"},{"issue":"6","key":"5328_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569\u2013575","journal-title":"JAMA"},{"issue":"18","key":"5328_CR12","first-page":"30380","volume":"5","author":"V Galimberti","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M et al (2018) Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol 5(18):30380\u201330382","journal-title":"Lancet Oncol"},{"issue":"1","key":"5328_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","volume":"17","author":"J de Boniface","year":"2017","unstructured":"de Boniface J, Frisell J, Andersson Y, Bergkvist L, Ahlgren J, Ryden L, Olofsson Bagge R, Sund M, Johansson H, Lundstedt D (2017) Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial. BMC Cancer 17(1):379","journal-title":"BMC Cancer"},{"issue":"3","key":"5328_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.adro.2018.03.004","volume":"3","author":"BJ Gebhardt","year":"2018","unstructured":"Gebhardt BJ, Thomas J, Horne ZD, Champ CE, Farrugia DJ, Diego E, Ahrendt GM, Beriwal S (2018) Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial? Adv Radiat Oncol 3(3):258\u2013264","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"5328_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1503\/cjs.036011","volume":"55","author":"S Latosinsky","year":"2012","unstructured":"Latosinsky S, Berrang TS, Cutter CS, George R, Olivotto I, Julian TB, Hayashi A, Baliski C, Croshaw RL, Erb KM et al (2012) CAGS and ACS evidence based reviews in surgery. 40: axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis. Can J Surg 55(1):66\u201369","journal-title":"Can J Surg"},{"issue":"5","key":"5328_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000491704","volume":"13","author":"J de Boniface","year":"2018","unstructured":"de Boniface J, Schmidt M, Engel J, Smidt ML, Offersen BV, Reimer T (2018) What is the best management of cN0pN1(sn) breast cancer patients? Breast Care 13(5):331\u2013336","journal-title":"Breast Care"},{"issue":"4","key":"5328_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 14(4):297\u2013305","journal-title":"Lancet Oncol"},{"issue":"3","key":"5328_CR18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252(3):426\u2013432","journal-title":"Ann Surg"},{"issue":"5","key":"5328_CR19","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1510059","volume":"375","author":"I Ford","year":"2016","unstructured":"Ford I, Norrie J (2016) Pragmatic trials. N Engl J Med 375(5):454\u2013463","journal-title":"N Engl J Med"},{"key":"5328_CR20","unstructured":"Nationellt kvalitetsregister f\u00f6r br\u00f6stcancer [ https:\/\/statistik.incanet.se\/brostcancer\/ ]"},{"issue":"1","key":"5328_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12889-019-6846-6","volume":"19","author":"L Lofgren","year":"2019","unstructured":"Lofgren L, Eloranta S, Krawiec K, Asterkvist A, Lonnqvist C, Sandelin K (2019) Validation of data quality in the Swedish National Register for Breast Cancer. BMC Public Health 19(1):495","journal-title":"BMC Public Health"},{"issue":"4","key":"5328_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 14(4):297\u2013305","journal-title":"Lancet Oncol"},{"issue":"1","key":"5328_CR23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/000313481608200124","volume":"82","author":"TC Kenny","year":"2016","unstructured":"Kenny TC, Dove J, Shabahang M, Woll N, Hunsinger M, Morgan A, Blansfield J (2016) Widespread implications of ACOSOG Z0011: effect on total mastectomy patients. Am Surg 82(1):53\u201358","journal-title":"Am Surg"},{"key":"5328_CR24","unstructured":"Validering av Nationellt kvalitetsregister f\u00f6r br\u00f6stcancer [ https:\/\/www.cancercentrum.se\/globalassets\/cancerdiagnoser\/brost\/kvalitetsregister\/rapport_master_validering_brostregister2015-10-14.pdf ]"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05328-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05328-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05328-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T19:00:39Z","timestamp":1663786839000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05328-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["5328"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05328-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2019,6,24]]},"assertion":[{"value":"14 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the respective regional ethics committees and the central ethics committee in Stockholm (no. 2013\/1258-31\/4).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}